Estimation of the time course of slow-wave sleep over the night in depressed patients: Effects of clomipramine and clinical response

Biological Psychiatry

Volumn 39, Issue 3, 1996, Pages 171-181

  Ehlers, Cindy L ^a   Havstad, James W ^b   Kupfer, David J ^b  

^a ILTAB   (United States)

^b NONE

Author keywords

Antidepressants; Major affective disorder; S process; Sleep models; Slow wave sleep; Spectral analyses

Indexed keywords

CLOMIPRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW WAVE SLEEP; TIME;

EID: 0030045887     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00139-5     Document Type: Article

References (52)

1. Achermann P, Borbely AA (1990): Simulation of human sleep: Ultradian dynamics of Electroencephalographic slow-wave activity. J Biol Rhythms 5(2):141-157.
2. Achermann P, Derk-Jan D, Brunner DP, Borbely AA (1993): A model of human sleep homeostasis based on EEG slow-wave activity: Quantitative comparison of data and simulations. Brain Res Bull 31:97-113.
3. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP (1994): The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacol 10(2):123-127.
4. Beersma DGM, van den Hoofdakker RH (1992): Can non-REM sleep be depressogenic? J Affective Disorders 24:101-108.
5. Berger M, Emrich HM, Lund D, Reimann D, Lauer C (1986): Sleep-EEG variables as course criteria and predictors of antidepressant therapy with fluvoxamine/oxaprotiline. Adv Pharmacother 2:110-120.
6. Borbely (1982): A two-process model of sleep regulation. Hum Neurobiol 1:195-204.
7. Borbely AA (1988): The two-process model of sleep regulations: Implications for sleep in depression. In: Kupfer DJ, Monk TH, Barchas JD (eds): Biological Rhythms and Mental Disorders. New York and London: The Guilford Press, Chapters, pp 55-81.
8. Borbely AA, Achermann P (1992): Concepts and models of sleep regulation, an overview. J Sleep Res 1:63-79.
9. Borbely AA, Tobler I, Loepfe M, Kupfer DJ, Ulrich RF, Grochocinski V, Dorman J, Matthews G (1984): All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Res 12:27-33.
10. Borbely AA, Wirz-Justice A (1982): Sleep, sleep deprivation and depression: A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1:205-210.
11. Chen C (1979): Sleep, depression, and antidepressants. Br J Psychiatry 135:385-402.
12. Ciapparelli A, Dani A, Figura A, Germignani A, Guazzelli M (1992): The effects of fluoxetine (FL) on sleep pattern: A clinical and all-night EEG study in patients with major depression. J Sleep Res 1:41.
13. Daan S, Beersma DGM, Borbely AA (1984): Timing of human sleep: Recovery process gated by a circadian pacemaker. Am J Physiol 246:R161-R178.
14. Ehlers CL, Havstad JW (1982): Characterization of drug effects on the EEG by power spectral band time series analysis. Psychopharmacol Bull 18(3):43-47.
15. Ehlers CL, Kupfer DJ (1987): Hypothalamic peptide modulation of EEG sleep in depression: A further application of the S-process hypothesis. Biol Psychiatry 22:513-517.
16. Endicott J, Spitzer RL (1978): A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
17. Gillin JC, Wyatt RJ, Fram D, Snyder F (1978): The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitryptyline. Psychopharmacology 59:267-272.
18. Hamilton M (1967): Development of a rating scale for primary depressive illness. Br J Social Clin Psychology 6:278-296.
19. Hochli D, Reimann D, Zulley J, Berger M (1986): Initial REM sleep suppression by clomipramine: A prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry 21:1217-1220.
20. Kupfer DJ, Ehlers CL (1989): Two roads to rapid eye movement latency. Arch Gen Psychiatry 46:945-948.
21. Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, McEachran AB, Buhari A (1993): Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry 34:753-758.
22. Kupfer DJ, Ehlers CL, Pollock BG, Nathan RS, Perel JM (1989): Clomipramine and EEG sleep in depression. Psychiatry Res 30:165-180.
23. Kupfer DJ, Foster FG, Reich L, Thompson KS, Weiss R (1976): EEG sleep changes as predictors in depression. Am J Psychiatry 133:622-626.
24. Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ (1990): A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 47:1100-1105.
25. Kupfer DJ, Pollock BG, Perel JM, Miewald BA, Grochocinski VJ, Ehlers CL (in press): Effect of pulse loading with clomipramine on EEG sleep. Psychiatry Res.
26. Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski VJ, Wilson MJ, McEachran AB (1991): Fluvoxamine versus desipramine: Comparative polysomnographic effects. Biol Psychiatry 29:23-40.
27. Kupfer DJ, Shipley JE, Perel JM, Pollock B, Coble PA, Spiker DG (1987): Antidepressants and EEG sleep: Search for specificity. In: Dahl SG, Gram LF, Paul SM, Potter WZ (eds): Clinical Pharmacology in Psychiatry: Selectivity in Psychotropic Drug Action - Promises or Problem? New York, NY: Springer-Verlag (Psychopharmacology Series 3), pp 167-173.
28. Kupfer DJ, Spiker DG, Rossi A, Coble PA, Ulrich RF, Shaw DH (1981): Sleep treatment prediction in endogenous depression. Am J Psychiatry 138:429-434.
29. Kupfer DJ, Spiker DG, Rossi A, Coble PA, Ulrich RF, Shaw DH (1983): Recent diagnostic and treatment advances in REM sleep and depression. In: Clayton P, Barrett J (eds): Treatment of Depression: Old Controversies and New Approaches. New York, NY: Raven Press, pp 31-52.
30. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski V, Doman J, Matthews G, Borbely AA (1984): Application of automated REM and slow-wave sleep analysis: II. Testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatry Res 13:335-343.
31. Mendelson WB, Sack DA, James SP, Martin JV, Wagner R, Garnett D, Milton J, Wehr TA (1987): Frequency analysis of the sleep EEG in depression. Psychiatry Res 21:89-94.
32. Monti JM (1989): Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry Suppl 155:61-65.
33. Monti JM, Alterwain P, Monti D (1990): The effects of moclobemide on nocturnal sleep of depressed patients. J Affective Disorders 20(3):201-208.
34. Mouret J, Lemoine P, Minuit MP, Sanchez P, Taillard J (1989): Sleep polygraphic effects of trimipramine in depressed patients. Drugs 38 Suppl 1:14-16.
35. Oswald I, Adam K (1986): Effects of paroxetine on human sleep. Br J Clin Pharmacol 22:97-99.
36. Pollock BG, Perel JM, Kupfer DJ, Bowler KA, Miewald JM (1993): Early response patterns associated with successful clomipramine treatment. J Clin Psychopharmacol 13:442-447.
37. Pollock BG, Perel JM, Nathan RS, Kupfer DJ (1989): Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. Arch Gen Psychiatry 46:29-35.
38. Press WH, Flannery BP, Teukolsky SA, Vetterling WT (1986): Numerical Recipes, 1st ed. Cambridge, UK: University Press, pp 312-326.
39. Raskin A, Schulterrbrandt J, Reatig N, McKeon JJ (1969): Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nervous Mental Disease 148:87-98.
40. Reynolds CF, Kupfer DJ (1987): Sleep research in affective illness: State of the art circa 1987 (State-of-the-art review). Sleep 10:199-215.
41. Riemann D, Berger M (199O): The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 81:24-31.
42. Sharpley AL, Walsh AES, Cowen PJ (1992): Nefazodone - a novel antidepressant - may increase REM sleep. Biol Psychiatry 31:1070-1073.
43. Shipley JE, Kupfer DJ, Dealy RS, Coble PA, McEachran AB, Grochocinski VJ, Ulrich R, Perel JM (1985): Comparison of effects of desipramine and amitryptyline on EEG of sleep of depressed patients. Psychopharmacol 85:14-22.
44. Shipley JE, Kupfer DJ, Dealy RS, Griffin SJ, Coble PA, McEachran AB, Grochocinski VJ (1984): Differential effects of amitryptyline and zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther 36:251-259.
45. Spitzer RL, Endicott J, Robins E (1978): Research diagnostic criteria. Arch Gen Psychiatry 35:773-882.
46. Staner L, Kerkhofs M, Detroux D, et al (1992): A double-blind comparison of the effects of paroxetine and amitryptyline on sleep EEG patients with major depression. J Sleep Res 1:218.
47. Tobler I, Franken P, Trachel L, Borbely AA (1992): Models of sleep regulation in mammals. J Sleep Res 1:125-127.
48. Vogel GW, Thurmond A, Gibbons P, Sloan K, Boyd M, Walker M (1975): REM sleep reduction effects on depression syndromes. Arch Gen Psychiat 32:765-777.
49. Ware JC, Brown FW, Morrad PJ Jr, Pittard JT, Cobert B (1989): Effects on sleep: A double-blind study comparing trimipramine to imipramine in depressed insonmiac patients. Sleep 12(6):537-549.
50. Ware JC, Rose V, McBrayer R (1991): The effects of nefazodone, trazodone, buspirone and placebo on sleep and sleep related penile erections (NPT) in normal subjects. Sleep Res 20:91.
51. Wiegand M, Berger M (1989): Action of trimipramine on sleep and pituitary hormone secretion. Drugs 38 Suppl 1:35-42.
52. Zung WW (1969): Effect of antidepressant drugs on sleeping and dreaming: III. On the depressed patient. Biol Psychiatry 1:283-287.